The mechanisms by which cAMP mediates apoptosis are not well understood. In the current studies, we used wild-type (WT) S49 T-
lymphoma cells and the kin(-) variant (which lacks
protein kinase A (PKA)) to examine cAMP/PKA-mediated apoptosis. The cAMP analog,
8-CPT-cAMP, increased phosphorylation of the
cAMP response element-binding protein (CREB), activated
caspase-3, and induced apoptosis in WT but not in kin(-) S49 cells. Using an array of 96 apoptosis-related genes, we found that treatment of WT cells with
8-CPT-cAMP for 24 h induced expression of
mRNA for the pro-apoptotic gene, Bim. Real-time PCR analysis indicated that
8-CPT-cAMP increased Bim
RNA in WT cells in <2 h and maintained this increase for >24 h.
Bim protein expression increased in WT but not kin(-) cells treated with
8-CPT-cAMP or with the
beta-adrenergic receptor agonist isoproterenol. Both apoptosis and Bim expression were reversible with removal of
8-CPT-cAMP after <6 h. The
glucocorticoid dexamethasone also promoted apoptosis and Bim expression in S49 cells. In contrast, both UV light and anti-mouse Fas
monoclonal antibody promoted apoptosis in S49 cells but did not induce Bim expression.
8-CPT-cAMP also induced Bim expression and enhanced
dexamethasone-promoted apoptosis in human
T-cell leukemia CEM-C7-14 (
glucocorticoid-sensitive) and CEM-C1-15 (
glucocorticoid-resistant) cells; increased Bim expression in 8-CPT-cAMP-treated CEM-C1-15 cells correlated with conversion of the cells from resistance to sensitivity to
glucocorticoid-promoted apoptosis. Induction of Bim appears to be a key event in cAMP-promoted apoptosis in both murine and human
T-cell lymphoma and
leukemia cells and thus appears to be a convergence point for the killing of such cells by
glucocorticoids and agents that elevate cAMP.